rxstat › Drug prices › Vandetanib

Vandetanib (Caprelsa) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Vandetanib 100 mg tablet costs about $99.16 per tablet on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.

Vandetanib has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABNBNS
100 mg Tabletper tablet$99.16not covered$99.16$99.16
300 mg Tabletper tablet$198.31not covered$198.31$198.31
Plan coverageNot coveredSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 2 products
  • Caprelsa 100 mg Tablet · SAV
    DIN 02378582 · $99.16/tablet · Not covered
  • Caprelsa 300 mg Tablet · SAV
    DIN 02378590 · $198.31/tablet · Not covered
New Brunswick: 2 products
  • Caprelsa 100 mg Tablet · MDU
    DIN 02378582 · $99.16/tablet · Special approval
  • Caprelsa 300 mg Tablet · MDU
    DIN 02378590 · $198.31/tablet · Special approval
Nova Scotia: 2 products
  • Caprelsa 100 mg Tablet · SAV
    DIN 02378582 · $99.16/tablet · Special approval
  • Caprelsa 300 mg Tablet · SAV
    DIN 02378590 · $198.31/tablet · Special approval

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 2
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Resolved
CAPRELSA
100MG · TABLET · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02378582 · ended Feb 7, 2023
Avoided
CAPRELSA
100MG · TABLET · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02378582 · ended Jun 30, 2022
Avoided
CAPRELSA
300MG · TABLET · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02378590 · ended Apr 7, 2022

What's happening

There are no active shortage reports for Vandetanib. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Vandetanib is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XE).

Recent changes

Common questions

How much does Vandetanib cost in Canada?

Vandetanib 100 mg tablet costs about $99.16 per tablet on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.

Is Vandetanib covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Vandetanib be back in stock in Canada?

Vandetanib has no active shortage; supply is normal per Health Canada reports.

Why is Vandetanib in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other antineoplastic agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.